(Q42241649)

19 October 2017

Lyme disease in the United Kingdom. (English)

1 reference

19 October 2017

0 references

Simon W Dubrey

1

1 reference

19 October 2017

Ajay Bhatia

series ordinal

2

1 reference

19 October 2017

Sarah Woodham

series ordinal

3

1 reference

19 October 2017

Wojtek Rakowicz

series ordinal

4

1 reference

19 October 2017

language of work or name

English

0 references

publication date

6 November 2013

1 reference

Postgraduate Medical Journal

19 October 2017

1 reference

19 October 2017

90

1 reference

19 October 2017

1059

1 reference

19 October 2017

33-42

1 reference

Lyme disease surveillance in England and Wales, 1986 1998.

19 October 2017

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Lyme disease: a growing threat to urban populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Lyme disease in the U.K.: clinical and laboratory features and response to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Prevalence of Borrelia burgdorferi sensu lato genospecies in Ixodes ricinus ticks in Europe: a metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Abundance estimation of Ixodes ticks (Acari: Ixodidae) on roe deer (Capreolus capreolus).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Determining the tick scutal index allows assessment of tick feeding duration and estimation of infection risk with Borrelia burgdorferi sensu lato in a person bitten by an Ixodes ricinus nymph.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Duration of tick attachment as a predictor of the risk of Lyme disease in an area in which Lyme disease is endemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

The epidemiology, prevention, investigation and treatment of Lyme borreliosis in United Kingdom patients: a position statement by the British Infection Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Lyme disease in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Experience of Lyme disease and preferences for precautions: a cross-sectional survey of UK patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Borrelia burgdorferi stimulates macrophages to secrete higher levels of cytokines and chemokines than Borrelia afzelii or Borrelia garinii

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Borrelia burgdorferi RST1 (OspC type A) genotype is associated with greater inflammation and more severe Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

The expanding Lyme Borrelia complex—clinical significance of genomic species?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Clinical presentation of childhood neuroborreliosis; neurological examination may be normal

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Neurologic aspects of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Neurologic manifestations of lyme disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Nervous system lyme disease: is there a controversy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Lyme carditis: an important cause of reversible heart block

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Lyme carditis in children: presentation, predictive factors, and clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Range of atrioventricular conduction disturbances in Lyme borreliosis: a report of four cases and review of other published reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

The epidemiology of infectious myocarditis, lymphocytic myocarditis and dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Fatal Lyme carditis and endodermal heterotopia of the atrioventricular node

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Postmortem confirmation of Lyme carditis with polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Sudden cardiac death in young athletes: orienteering on Chlamydia pneumoniae?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Coinfections Acquired from Ixodes Ticks

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Subacute bartonella infection in Swedish orienteers succumbing to sudden unexpected cardiac death or having malignant arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Chronic Lyme Disease and Co-infections: Differential Diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Early disseminated Lyme disease: cardiac manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Cardiac manifestations of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Paradigm Burgenland: risk of Borrelia burgdorferi sensu lato infection indicated by variable seroprevalence rates in hunters

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

No evidence to implicate Borrelia burgdorferi in the pathogenesis of dilated cardiomyopathy in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Study on microbial persistence in end-stage idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

The early clinical manifestations of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

21 January 2018

Chronic Lyme Arthritis

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Elucidation of Lyme arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Evidence of Borrelia Autoimmunity-Induced Component of Lyme Carditis and Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Borrelia infection and risk of non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Lyme borreliosis: current issues in diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Detection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Minocycline for short-term neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Lyme Disease in Pregnancy: Case Report and Review of the Literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Maternal Lyme borreliosis and pregnancy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

A Critical Appraisal of “Chronic Lyme Disease”

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Scientific evidence and best patient care practices should guide the ethics of Lyme disease activism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Differentiation of reinfection from relapse in recurrent Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Review of evidence for immune evasion and persistent infection in Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Antibiotic treatment of animals infected with Borrelia burgdorferi

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Detection of Borrelia burgdorferi DNA in muscle of patients with chronic myalgia related to Lyme disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Human Borrelia miyamotoi infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Chronic Lyme disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Chronic Lyme disease: the controversies and the science

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Chronic Lyme disease and the 'Axis of Evil'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Lyme disease in a British referral clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Psychiatric comorbidity and other psychological factors in patients with "chronic Lyme disease".

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Efficacy of a long-term antibiotic treatment in patients with a chronic Tick Associated Poly-organic Syndrome (TAPOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Antibiotic retreatment of Lyme disease in patients with persistent symptoms: a biostatistical review of randomized, placebo-controlled, clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Point: antibiotic therapy is not the answer for patients with persisting symptoms attributable to lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Treatment trials for post-Lyme disease symptoms revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

A reappraisal of the u.s. Clinical trials of post-treatment lyme disease syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Antiscience and ethical concerns associated with advocacy of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Common misconceptions about Lyme disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Rapid, simple, quantitative, and highly sensitive antibody detection for lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Direct molecular detection and genotyping of Borrelia burgdorferi from whole blood of patients with early Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Outer surface protein C peptide derived from Borrelia burgdorferi sensu stricto as a target for serodiagnosis of early lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Treatment of infection caused by Borrelia burgdorferi sensu lato

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Lyme borreliosis vaccination: the facts, the challenge, the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Vaccination against Lyme disease: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Taxonomic classification of 29 Borrelia burgdorferi strains isolated from patients with Lyme borreliosis: a comparison of five different phenotypic and genotypic typing schemes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

Neuroborreliosis in the South West of England

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FPOSTGRADMEDJ-2012-131522

10.1136/POSTGRADMEDJ-2012-131522

21 January 2018

Identifiers

DOI

1 reference

19 October 2017

1 reference